One low-cost device: countless clinical, cost and prescribing benefits.
Peezy saves money, reduces false-positive and contaminated urine samples and facilitates targeted antibiotic prescribing.
“ Peezy Midstream … is the only urine collection method that meets Public Health England’s UK Standards for Microbiology Investigation of Urine. ”
NICE: National Institute for Health and Clinical Excellence
MedTech Innovation Briefing Paper, May 2019
Urine is one of the most important carriers of cancer biomarkers, bacteria, protein, glucose and more, all of which can raise the alarm to serious illness. If left undiagnosed these conditions can become far more difficult and costly to treat.
Yet there is no gold standard for urine collection anywhere in the world, leaving patients vulnerable to failed diagnosis and failed treatment:
- 50% AMR incidences have a urinary source
- 47% Gram-negative blood infections caused by urinary tract infection
- 22% Average unreliable urine specimens (USA and UK)
Forte Medical has developed world-first technology that delivers super-accurate urine specimens and right-first-time preventative urine-based medicine. Peezy Midstream reduces specimen contamination to just 1-2.5%, delivering diagnostic integrity, targeted treatment.
At NHS West Hertfordshire Antenatal Clinic it has reduced false-positive dipped urines by almost 70%, significantly reducing samples sent to the lab unnecessarily, saving staff time, thousands for their department and reassuring patients too. Read the NICE MedTech Innovation Briefing Paper.
We are now developing The Specimen Collection, a portfolio of devices designed to help with identification of early stage cancers including prostate, testicular, cervical, bladder, kidney and more. Smart digital solutions are planned for each product.
Peezy Midstream is MHRA registered, FDA listed and patented.
For more information please contact us.